Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

Clicks: 227
ID: 273088
2005
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In 2003-2004, there was an increase in the proportion of patients with CDAD believed, by their attending physicians, to have experienced metronidazole treatment failure, as well as an increase in the frequency of post-metronidazole therapy recurrences, especially among elderly persons.
Reference Key
j2005clinicalincreasing Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pepin J;Alary ME;Valiquette L;Raiche E;Ruel J;Fulop K;Godin D;Bourassa C;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2005
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/15889355
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult adolescent aged middle aged Child Infant Recurrence preschool risk factors anti-bacterial agents / therapeutic use metronidazole / therapeutic use vancomycin / therapeutic use enterocolitis treatment failure quebec pmid:15889355 doi:10.1086/430315 jacques pepin marie-eve alary claude bourassa pseudomembranous / drug therapy*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.